← Back to Patent Explorer
US4604356A Expired / Lapsed US ⏱️ 0.0 years remaining

Purification of flavin adenine dinucleotide synthetase

Assignee: Bayer Corp
•
Filing: 1983-12-21
•
Granted: 1986-08-05
•
Expires: 2003-12-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a flavin adenine dinucleotide (FAD) synthetase preparation with a specific activity at 25 DEG C. greater than at least 75 nanomoles per minute per milligram of protein in the preparation and usually greater than at least 150 nanomoles per minute per milligram of protein in the preparation as measured utilizing flavin mononucleotide (FMN) as the substrate. The purified preparation is obtained by disrupting a cellular source of FAD synthetase activity, precipitating the protein and separating an FAD synthetase active fraction by column chromatography. FAD synthetase catalyzes the reaction of adenosine triphosphate and flavin mononucleotide to flavin adenine dinucleotide and pyrophosphate, among others.

Inventors

  • 👤 II Robert C. Blake

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-03 08:45
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/10; C12N9/12; C12P; C12P19/00; C12P19/26; C12P19/28; C12P19/30; C12P19/32; C12P25/00

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 234 words
A method for purifying flavin adenine dinucleotide synthetase comprising the steps of: (a) disrupting cells containing flavin adenine dinucleotide synthetase activity, (b) separating a liquid fraction, (c) treating the separated liquid fraction with a protein precipitating agent, (d) separating the precipitated protein, (e) applying a solution of the precipitated protein to a chromatography column containing a moiety selective for flavin adenine dinucleotide synthetase, (f) eluting the chromatography column with a first eluting solution containing one of (1) flavin mononucleotide or an effective analogue thereof or (2) adenosine triphosphate or an effective analogue thereof and a divalent cation, as a first eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (g) applying the collected fraction to a chromatography column containing a molecular sieve capable of excluding molecules greater than at least about 10 5 daltons, eluting and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (h) applying the collected fraction to a second chromatography column containing a moiety selective for flavin adenine dinucleotide synthetase, (i) eluting the second chromatography column with a second eluting solution containing the other of (1) flavin mononucleotide or an effective analogue thereof or (2) adenosine triphosphate or an effective analogue thereof and a divalent cation, not present in said first eluting solution, as a second eluent, and collecting a fraction containing flavin adenine dinucleotide cleotide synthetase activity, and (j) removing said second eluent from the collected fraction.
Claim 2
Independent Claim 234 words
A method for purifying flavin adenine dinucleotide synthetase comprising the steps of: (a) disrupting cells containing flavin adenine dinucleotide synthetase activity, (b) separating a liquid fraction, (c) treating the separated liquid fraction with a protein precipitating agent, (d) separating the precipitated protein, (e) applying a solution of the precipitated protein to a chromatography column containing a moiety selective for flavin adenine dinucleotide synthetase, (f) eluting the chromatography column with a first eluting solution containing one of (1) flavin mononucleotide or an effective analogue thereof or (2) adenosine triphosphate or an effective analogue thereof and a divalent cation, as a first eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (g) applying the collected fraction to a chromatography column containing a molecular sieve capable of excluding molecules greater than at least about 10 5 daltons, eluting and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (h) applying the collected fraction to a second chromatography column containing a moiety selective for flavin adenine dinucleotide synthetase, (i) eluting the second chromatography column with a second eluting solution containing the other of (1) flavin mononucleotide or an effective analogue thereof or (2) adenosine triphosphate or an effective analogue thereof and a divalent cation, not present in said first eluting solution, as a second eluent, and collecting a fraction containing flavin adenine dinucleotide cleotide synthetase activity, and (j) removing said second eluent from the collected fraction.
Claim 3
Dependent Claim 19 words
The method of claim 1 wherein the cells containing flavin adenine dinucleotide synthetase activity comprise a Brevibacterium ammoniagenes culture.
Claim 4
Dependent Claim 19 words
The method of claim 1 or 2 wherein the moiety selective for flavin adenine dinucleotide synthetase is a dye-ligand.
Claim 5
Dependent Claim 16 words
The method of claim 3 wherein the same dye-ligand is used in steps (e) and (h).
Claim 6
Dependent Claim 14 words
The method of claim 4 wherein the dye-ligand is Reactive Blue-2 (color index 61211).
Claim 7
Dependent Claim 12 words
The method of claim 1 wherein the first eluent is flavin mononucleotide.
Claim 8
Dependent Claim 17 words
The method of claim 6 wherein the concentration of flavin mononucleotide is from 4 millimolar to saturation.
Claim 9
Dependent Claim 16 words
The method of claim 7 wherein the second eluent is adenosine triphosphate and a divalent cation.
Claim 10
Dependent Claim 18 words
The method of claim 8 wherein the concentration of adenosine triphosphate is from 200 micromolar to 2 millimolar.
Claim 11
Dependent Claim 16 words
The method of claim 8 wherein divalent cation in the second eluting solution is magnesium cation.
Claim 12
Dependent Claim 36 words
The method of claim 1 wherein the removal of the second eluent is accomplished by use of a chromatography column containing a molecular seive capable of excluding molecules greater than at least about 10 5 daltons.
Claim 13
Dependent Claim 40 words
A preparation of flavin adenine dinucleotide synthetase produced according to the method of claim 1 and having a specific activity of at least 75 nanomoles per minute per milligram of protein at 25° C. with flavin mononucleotide as the substrate.
Claim 14
Dependent Claim 40 words
A preparation of flavin adenine dinucleotide synthetase produced according to the method of claim 1 and having a specific activity of at least 150 nanomoles per minute per milligram of protein at 25° C. with flavin mononucleotide as the substrate.
Claim 15
Independent Claim 177 words
A method for purifying flavin adenine dinucleotide synthetase comprising the steps of: (a) disrupting cells of a Brevibacterium ammoniagenes culture, (b) separating a liquid fraction, (c) treating the separated liquid fraction with a protein precipitating agent, (d) separating the precipitated protein, (e) applying a solution of the precipitated protein to a chromatography column containing Reactive Blue 2, (f) eluting the chromatography column with a first eluting solution containing flavin mononucleotide as a first eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (g) applying the collected fraction to a chromatography column containing a molecular sieve capable of excluding molecules greater than at least about 10 5 daltons, eluting and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (h) applying said collected fraction to a second selective chromatography column containing Reactive Blue 2, (e) eluting the second chromatography column with a second eluting solution containing adenosine triphosphate and a divalent cation as the second eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, and (j) removing said second eluent from the collected fraction.
Claim 16
Independent Claim 177 words
A method for purifying flavin adenine dinucleotide synthetase comprising the steps of: (a) disrupting cells of a Brevibacterium ammoniagenes culture, (b) separating a liquid fraction, (c) treating the separated liquid fraction with a protein precipitating agent, (d) separating the precipitated protein, (e) applying a solution of the precipitated protein to a chromatography column containing Reactive Blue 2, (f) eluting the chromatography column with a first eluting solution containing flavin mononucleotide as a first eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (g) applying the collected fraction to a chromatography column containing a molecular sieve capable of excluding molecules greater than at least about 10 5 daltons, eluting and collecting a fraction containing flavin adenine dinucleotide synthetase activity, (h) applying said collected fraction to a second selective chromatography column containing Reactive Blue 2, (e) eluting the second chromatography column with a second eluting solution containing adenosine triphosphate and a divalent cation as the second eluent, and collecting a fraction containing flavin adenine dinucleotide synthetase activity, and (j) removing said second eluent from the collected fraction.
Claim 17
Dependent Claim 22 words
The method of claim 14 wherein the concentration of flavin mononucleotide in the first eluting solution is from 4 millimolar to saturation.
Claim 18
Dependent Claim 18 words
The method of claim 14 wherein the concentration of adenosine triphosphate is from 200 micromolar to 2 millimolar.
Claim 19
Dependent Claim 36 words
The method of claim 14 wherein the removal of the second eluent is accomplished by means of a chromatography column containing a molecular sieve capable of excluding molecules greater than at least about 10 5 daltons.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-08-04 1990-02-03 1990-08-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-08-04 1994-02-03 1994-08-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-08-04 1998-02-03 1998-08-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag